AryoGen Pharmed has put into practice the following principles as the leading quality policy with the thought of serving life-threatening illnesses based on the modern science of biotechnology and global standards.
Application and development of new technologies used in production and quality control of biological products.
Commitment to the provision of global effective and safe medicines and services through development, production, distribution and marketing in accordance with legal requirements and organizational values and the latest scientific findings.
Commitment and focus on continuous product improvement and process operation.
Enhancing participation in the organization through empowering, raising awareness and organizational motivation.
Adopting methods for preventing and controlling environmental pollution through the identification and implementation of national and international requirements.
Interacting with formal institutions and relevant public-sector organizations for performing social responsibilities.
We are committed to meet the requirements of ISO9001:2015 and EU GMP and to enhance the knowledge and culture of the organization in the field of quality at all levels, and will do our best to accomplish this.
Biopharmaceutical production applying cutting edge biotechnology practices and manufacturing technology transfer
Increasing the quality and availability of biopharmaceutical products in order to improve quality of life of global community
Achieving the first rank in development, production and export of biopharmaceuticals in the region over the next 5 years
Winning 5% of Iran's market share over the next 5 year